ArticleCardiovascular diabetology2025

Exploring the effect of dapagliflozin on coronary inflammation in type 2 diabetes patients based on the coronary artery perivascular fat attenuation index.

Xuehua Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.